Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goebell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Urology|October 6, 2000
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinomaK H Franke, M Miklosi, P Goebell, et al.
Der Urologe. Ausg. A|October 27, 2017
[Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data]J E Gschwend, P Albers, M Bögemann, et al.
Der Urologe. Ausg. A|July 15, 2016
[Generation Y : Problem or solution in daily clinical practice]P Goebell, J Salem, J Strunk, et al.
Der Urologe. Ausg. A|October 26, 2016
[Erratum to: Generation Y - problem or solution in daily clinical practice]P Goebell, J Salem, J P Struck, et al.
European Urology|January 1, 1997
p53 and MDM2 in the development and progression of bladder cancerB J Schmitz-Dräger, M Kushima, P Goebell, et al.
Der Urologe. Ausg. A|May 30, 2018
[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts]M Schostak, F König, M Bögemann, et al.
Der Urologe. Ausg. A|November 3, 2020
[Certified residency curriculum for the specialization training in urology from the German Society of Urology according to the 2018 Training Regulations (version of 20. September 2019)]M S Michel, M Himmler, U Necknig, et al.
Urologic Oncology|October 20, 2022
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part IIIM J Reike, M A Ingersoll, D C Müller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Urology|October 6, 2000
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinomaK H Franke, M Miklosi, P Goebell, et al.
Der Urologe. Ausg. A|October 27, 2017
[Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data]J E Gschwend, P Albers, M Bögemann, et al.
Der Urologe. Ausg. A|July 15, 2016
[Generation Y : Problem or solution in daily clinical practice]P Goebell, J Salem, J Strunk, et al.
Der Urologe. Ausg. A|October 26, 2016
[Erratum to: Generation Y - problem or solution in daily clinical practice]P Goebell, J Salem, J P Struck, et al.
European Urology|January 1, 1997
p53 and MDM2 in the development and progression of bladder cancerB J Schmitz-Dräger, M Kushima, P Goebell, et al.
Der Urologe. Ausg. A|May 30, 2018
[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts]M Schostak, F König, M Bögemann, et al.
Der Urologe. Ausg. A|November 3, 2020
[Certified residency curriculum for the specialization training in urology from the German Society of Urology according to the 2018 Training Regulations (version of 20. September 2019)]M S Michel, M Himmler, U Necknig, et al.
Urologic Oncology|October 20, 2022
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part IIIM J Reike, M A Ingersoll, D C Müller, et al.
Pageof 1